Across the recent three months, 9 analysts have shared their insights on Skyward Specialty (NASDAQ:SKWD), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 7 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 2 | 1 | 0 | 0 |
Analysts have recently evaluated Skyward Specialty and provided 12-month price targets. The average target is $42.67, accompanied by a high estimate of $46.00 and a low estimate of $37.00. This current average has increased by 6.38% from the previous average price target of $40.11.
Deciphering Analyst Ratings: An In-Depth Analysis
The perception of Skyward Specialty by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Matthew Carletti | JMP Securities | Raises | Market Outperform | $45.00 | $42.00 |
| Matthew Carletti | JMP Securities | Raises | Market Outperform | $42.00 | $40.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $44.00 | $43.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Maintains | Outperform | $43.00 | $43.00 |
| Paul Newsome | Piper Sandler | Raises | Overweight | $46.00 | $43.00 |
| Michael Zaremski | BMO Capital | Raises | Market Perform | $37.00 | $31.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $43.00 | $41.00 |
| Mark Hughes | Truist Securities | Raises | Buy | $44.00 | $40.00 |
| Matthew Carletti | JMP Securities | Raises | Market Outperform | $40.00 | $38.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Skyward Specialty. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Skyward Specialty compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Skyward Specialty's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Skyward Specialty's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Skyward Specialty analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Delving into Skyward Specialty's Background
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
Breaking Down Skyward Specialty's Financial Performance
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Skyward Specialty's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 31.75%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Skyward Specialty's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 11.68%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Skyward Specialty's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.86% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.0%, the company showcases effective utilization of assets.
Debt Management: Skyward Specialty's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.19.
How Are Analyst Ratings Determined?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.